Napoleone Ferrara
Napoleone Ferrara
Distinguished Professor and Senior Deputy Director for Basic Sciences, UCSD Moores Cancer Center
Verified email at ucsd.edu
TitleCited byYear
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz, L Fehrenbacher, W Novotny, T Cartwright, J Hainsworth, ...
New England journal of medicine 350 (23), 2335-2342, 2004
113112004
The biology of VEGF and its receptors
N Ferrara, HP Gerber, J LeCouter
Nature medicine 9 (6), 669-676, 2003
97782003
Vascular endothelial growth factor is a secreted angiogenic mitogen
DW Leung, G Cachianes, WJ Kuang, DV Goeddel, N Ferrara
58471989
The biology of vascular endothelial growth factor
N Ferrara, T Davis-Smyth
Endocrine reviews 18 (1), 4-25, 1997
56891997
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
KJ Kim, B Li, J Winer, M Armanini, N Gillett, HS Phillips, N Ferrara
Nature 362 (6423), 841-844, 1993
44291993
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
LP Aiello, RL Avery, PG Arrigg, BA Keyt, HD Jampel, ST Shah, ...
New England Journal of Medicine 331 (22), 1480-1487, 1994
40821994
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
N Ferrara, K Carver-Moore, H Chen, M Dowd, L Lu, KS O'Shea, ...
Nature 380 (6573), 439-442, 1996
39801996
Vascular endothelial growth factor: basic science and clinical progress
N Ferrara
Endocrine reviews 25 (4), 581-611, 2004
38382004
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
N Ferrara, WJ Henzel
Biochemical and biophysical research communications 161 (2), 851-858, 1989
34791989
Angiogenesis as a therapeutic target
N Ferrara, RS Kerbel
Nature 438 (7070), 967-974, 2005
27822005
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
C De Vries, JA Escobedo, H Ueno, K Houck, N Ferrara, LT Williams
Science 255 (5047), 989-991, 1992
24941992
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara, KJ Hillan, HP Gerber, W Novotny
Nature reviews Drug discovery 3 (5), 391-400, 2004
24782004
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway requirement for Flk-1/KDRá…
HP Gerber, A McMurtrey, J Kowalski, M Yan, BA Keyt, V Dixit, N Ferrara
Journal of Biological Chemistry 273 (46), 30336-30343, 1998
22961998
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
HP Gerber, TH Vu, AM Ryan, J Kowalski, Z Werb, N Ferrara
Nature medicine 5 (6), 623-628, 1999
20741999
Molecular and biological properties of the vascular endothelial growth factor family of proteins
N Ferrara, K Houck, LYN Jakeman, DW Leung
Endocrine reviews 13 (1), 18-32, 1992
20461992
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
LG Presta, H Chen, SJ O'connor, V Chisholm, YG Meng, L Krummen, ...
Cancer research 57 (20), 4593-4599, 1997
20401997
HIF-1α is essential for myeloid cell-mediated inflammation
T Cramer, Y Yamanishi, BE Clausen, I F÷rster, R Pawlinski, N Mackman, ...
Cell 112 (5), 645-657, 2003
17702003
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA
KA Houck, N Ferrara, J Winer, G Cachianes, B Li, DW Leung
Molecular endocrinology 5 (12), 1806-1814, 1991
17591991
VEGF and the quest for tumour angiogenesis factors
N Ferrara
Nature Reviews Cancer 2 (10), 795-803, 2002
16412002
Molecular and biological properties of vascular endothelial growth factor
N Ferrara
Journal of molecular medicine 77 (7), 527-543, 1999
15691999
The system can't perform the operation now. Try again later.
Articles 1–20